🇺🇸 FDA
Patent

US 8697730

5-lipoxygenase activating protein (FLAP) inhibitor

granted A61PA61P1/04A61P11/00

Quick answer

US patent 8697730 (5-lipoxygenase activating protein (FLAP) inhibitor) held by Panmira Pharmaceuticals, LLC expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/02, A61P11/06